Skip Ribbon Commands
Skip to main content

Dr Sumit Kumar Sonu

Dr Sumit Kumar Sonu

MBBS(India), MRCP(UK), MRCPE(Edin.) PGDip(Diabetes)USW,FAMS (Neurology), FRCP Edin.

Consultant

Clinical Appointments

  • Consultant, Department of Neurology, National Neuroscience Institute (NNI@SGH) Neurology Singapore General HospitalSingapore General Hospital
  • Fellow, Royal College of Physicians of Edinburgh
  • Fellow of Academy of Medicine Singapore, Chapter of Neurology

Academic Appointments

  • Core Faculty SingHealth Neurology Senior Residency
  • COMBINE (Collaboration for Mmed-FM programme B In Neurology Education) Programme Course director
  • Clinical Teacher, Lee Kong Chian School of Medicine
  • Clinical Instructor, Duke-NUS
  • PGY1 Faculty, Singapore General Hospital
  • Singapore General Hospital (Cadence PACES tutor)

Profile

Dr Sumit Kumar Sonu is a Consultant, Department of Neurology at the National Neuroscience Institute (NNI@SGH). He joined the SingHealth Internal Medicine Residency and subsequently completed his Senior Residency in Neurology in 2021.

Education

  • FRCP Edin. 2023
  • FAMS (Neurology)2021
  • SingHealth Neurology Senior Residency 2021
  • SingHealth Internal medicine Residency 2018
  • MRCP (UK), Neurology, 2020
  • Postgraduate Diploma in Diabetes, University of South Wales, UK, 2017
  • MRCP (UK), 2014
  • MBBS (Madras Medical College /Dr MGR Tamilnadu Medical University), 2008

Professional Appointments and Committee Memberships

  • Member, Word Stroke Organisation
  • Member, European Stroke Organisation
  • Member, American Academy of Neurology
  • Corresponding Member, European Academy of Neurology
  • Collegiate Member, Royal College of Physicians and Surgeons of Glasgow
  • Member of Society of Neurovascular Intervention and Surgery (Singapore )
  • Committee member of chapter of neurology, Fellow of Academy of Medicine Singapore

Awards

  • The COVID-19 RESILIENCE Medal 2023
  • SingHealth 10 years Long Service Award 2022
  • NNI 10 years Long Service Award 2022
  • Service with a Heart Award – SingHealth Service Quality Day 2021
  • IPSQ Poster Excellence Award – SingHealth Duke-NUS Quality & Innovation Day 2021
  • Certificate of Appreciation for Contribution in Fight Against COVID-19 – SingHealth Residency
  • Outstanding Resident Award – SingHealth RiSE Award 2020
  • Bronze Award – NNI Quality Improvement Project Award 2019
  • Best Quality Improvement Project Award – SingHealth Division of Medicine, Singapore General Hospital, 2018

Research Interests

Publications and Research Trials

  • Shawn Zhi Zheng Lin; Marco Lizwan; Mark Bangwei Tan; Sumit Kumar Sonu. Case of infiltrative optic neuropathy with hypertrophic pachymeningitis as a manifestation of en plaque meningioma. BMJ Case Reports 2023-12 | Journal article DOI: 10.1136/bcr-2023-257046 (Case report; Published in Print)
  • Sarah Hasnor Abu Hassan; Sumit Kumar Sonu. Paraneoplastic seropositive AQP4-IgG neuromyelitis optica spectrum disorder associated with sigmoid adenocarcinoma. Neurology Asia 2023; 28(3) : 769 – 774| Journal article. DOI: 10.54029/2023kvu Case report; Published in Print)
  • Marco Lizwan, Sumit Kumar Sonu. Bilateral Thalamic Infarction Caused by Artery of Percheron Obstruction. BMJ Case Rep. 2023 Jan 13;16(1):e253949. DOI: 10.1136/bcr-2022-253949. PMID: 36639198 (Case report; Published in Print)
  • Marco Lizwan; Shawn Zhi Zheng Lin; Sumit Kumar Sonu. Rare case of anti-CV2 paraneoplastic polyneuropathy associated with lung adenocarcinoma. BMJ Case Rep. 2023 Feb 3;16(2):e253686. DOI: 10.1136/bcr-2022-253686 PMID: 36737068 (Case report; Published in Print)
  • Sonu SK, Yong MH, Koh YH. Small fiber neuropathy in a patient with coronavirus disease 2019 (COVID-19). Neurol Asia. 2022 Mar; 27(1):195-197. doi: 10.54029/2022wzy. (Case report; Published in Print)
  • Sonu SK, Ng JCH, Chua SM, Kumar MP, De Silva D. Chorea precipitated by phototherapy as initial presentation of systemic lupus erythematosus. Ann Acad Med Singap. 2021 Oct;50(10):788-790. doi: 10.47102/annals-acadmedsg.2021137. PMID: 34755174. (Case report; Published in Print)
  • Tan JY, Sonu SK, Jion YBI, Umapathi T. Acute dysphagia. Pract Neurol. 2021 Jun;21(3):255-256. doi: 10.1136/practneurol-2020-002728. Epub 2021 Mar 1. PMID: 33649168. (Case report; Published in Print)
  • Sonu SK, Lalmalani Y, Kumar S, Verma, K. Acute acro-paraesthesia and bilateral clumsy hand syndrome rare presenting manifestation of vitamin B 12 deficiency: a case report highlighting clinico-radiological findings at diagnosis and follow-up. Neurol Asia. 2020 Dec; 25(4):627-630. Available from: https://imsva91-ctp.trendmicro.com:443/wis/clicktime/v1/query?url=https%3a%2f%2fwww.neurology%2dasia.org%2farticles%2fneuroasia%2d2020%2d25%284%29%2d627.pdf&umid=786A1719-0CF2-7506-BDBA-E033BFDFC045&auth=6e3fe59570831a389716849e93b5d483c90c3fe4-58819f2d4fc8f61a9967c6748888b56daf772106. (Case report; Published in Print)
  • Sonu SK, Lai YW, Verma K, Sitoh YY, Purohit B. Enterovirus-related rhombencephalitis and myelitis in the third trimester of pregnancy: A case report highlighting clinico-radiological findings at diagnosis and follow-up, Radiol Case Rep. 2020 Aug;15(8):1323-1330. doi: 10.1016/j.radcr.2020.05.062. Epub 2020 Jun 23. PMID: 32612733; PMCID: PMC7322137. (Case report; Published in Print)
  • Shekhawat RS, Lim WEH, Yong KP, De Silva DA, Sonu KS. “Heartbeat in the head”–An atypical presentation of dural arteriovenous malformation. Case Rep Intern Med. 2018 Oct; 5(4):19-22. doi: 10.5430/crim.v5n4p19. (Case report; Published in Print)

Research Trials

STROKE:
  • A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of Nerinetide in Participants with Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis (ESCAPE-NEXT)
  • TEMPO-2 acute stroke clinical trial
  • DIRECT-SAFE Clinical Trial
  • Brushing Up on Oral Hygiene - Perceptions and Practices of Stroke Survivors/ Caregivers on Oral Care in Stroke Patients
  • A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of MLC1501 in Patients with Stroke
  • Genetic Screening study of Young Ischemic Stroke patients (GeneSYIS)
  • A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack (LIBREXIA-STROKE)
  • A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke

HEADACHE:
  • A Real-life study of Eptinezumab (Vyepti) in Asian Patients with migraine (REAP STUDY)

PARKINSON’S:
  • A Phase IIb, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Dose-Titrations Study to Evaluate the Efficacy and Safety of AM006 in Patients with Early Parkinson 's Disease without Levodopa
  • Updated on